Overview
Roche Holding AG is a multinational healthcare company based in Basel, Switzerland. The company operates in the pharmaceuticals and diagnostics industries, making it a global leader in cancer treatments, in-vitro diagnostics, and tissue-based cancer diagnostics. Roche is heavily invested in research and development, with key projects focusing on areas such as oncology, neuroscience, infectious diseases, and immunology.
AI+ Ask Fintel’s AI assistant about Roche Holding AG.
Thinking about good questions…
Basic Stats
The share price of Roche Holding AG as of 8 September 2025 is CHF 270,10 / share. This is an increase of 3.80% from the prior week. The market cap (or net worth) of Roche Holding AG as of 8 September 2025 is CHF 232.739,87 MM.
The Factor Analysis chart (below right) shows a view of Roche Holding AG from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 232,739.87 MM |
| EV | 265,410.33 MM |
| Shares Out. | 796.32 MM |
| Earnings Date | |
| EPS (TTM) | 11.84 |
| Dividend Yield | 3.50 % |
| Ex-Dividend Date | 2025-03-27 |
| Borrow Rate | 0.57 |
| Short Shares Avail. | 10.00 MM |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.10 % |
| Price Change (1 yr) | 0.00 % |
| Volatility (1 yr) | 0.21 |
| Beta | 0.68 |
| Sharpe Ratio (1 yr) | -0.20 |
| Sortino Ratio (1 yr) | -0.29 |
| PE Ratio | 24.98 |
| Price/Book | 7.13 |
| Price/TBV | 54.20 |
| Book/Market | 0.14 |
| EBIT/EV | 0.05 |
| EBIT(3yr avg)/EV | 0.05 |
| ROA | 0.10 |
| ROE | 0.29 |
| ROIC | 0.14 |
| CROIC | 0.04 |
| OCROIC | 0.28 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 32.00 /100 |
| Profitability | 86.32 /100 |
| Quality Score | 81.01 /100 |
| Value Score | 67.83 /100 |
| Momentum Score | 42.83 /100 |
| Stability (Low Vol) Score | 86.40 /100 |
| Analyst Sentiment | 58.15 /100 |
| Fund Sentiment | 32.19 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | 61.85 /100 |
| QVM Score | |
| Piotroski F-SCORE | 8.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Roche Holding AG is CHF 304,58. The forecasts range from a low of CHF 237,35 to a high of CHF 459,90. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Roche Holding AG. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2019-01-28 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2019-01-28 | Argus | Buy | Initiate | |
| 2018-11-19 | Goldman Sachs | Conviction Buy | Buy | Downgrade |
| 2018-05-25 | Credit Suisse | Neutral | Underperform | Downgrade |
| 2018-05-10 | Bernstein | Outperform | Market Perform | Downgrade |
| 2015-01-08 | UBS | Buy | Neutral | Downgrade |
| 2014-03-13 | Morgan Stanley | Overweight | Initiate | |
| 2012-08-22 | JP Morgan | Neutral | Overweight | Upgrade |
| 2023-04-17 | DAY BY DAY | Buy | Sell | Downgrade |
| 2023-04-14 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-04-06 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-04-05 | BERENBERG | Hold | Buy | Upgrade |
| 2023-04-05 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-02-24 | WOLFE RESEARCH | Outperform | Outperform | Maintains |
| 2023-02-06 | DZ BANK | Hold | Hold | Maintains |
| 2023-02-03 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2023-01-10 | SOCIETE GENERALE | Buy | Hold | Downgrade |
| 2022-11-14 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2022-11-14 | COWEN AND COMPANY | Outperform | Outperform | Maintains |
| 2022-10-31 | DAY BY DAY | Buy | Buy | Maintains |
| 2022-08-12 | BERENBERG | Hold | Hold | Maintains |
| 2022-07-25 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-07-22 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2022-05-11 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2022-04-25 | DAY BY DAY | Buy | Buy | Maintains |
| 2022-04-01 | LIBERUM | Hold | Hold | Maintains |
| 2022-02-22 | HSBC | Hold | Hold | Maintains |
| 2021-10-21 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2021-04-01 | LIBERUM | Hold | Hold | Maintains |
| 2021-04-01 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-06-01 | BERENBERG | Hold | Buy | Upgrade |
| 2023-05-31 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-05-28 | DAY BY DAY | Buy | Sell | Downgrade |
| 2023-05-14 | SOCIETE GENERALE | Hold | Buy | Upgrade |
| 2023-05-09 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-05-07 | WOLFE RESEARCH | Outperform | Outperform | Maintains |
| 2023-04-26 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-04-26 | DZ BANK | Hold | Hold | Maintains |
| 2023-04-25 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2023-01-09 | SOCIETE GENERALE | Buy | Hold | Downgrade |
| 2022-11-13 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2022-11-13 | COWEN AND COMPANY | Outperform | Outperform | Maintains |
| 2022-10-30 | DAY BY DAY | Buy | Buy | Maintains |
| 2022-08-11 | BERENBERG | Hold | Hold | Maintains |
| 2022-07-24 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-07-21 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2022-05-10 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2022-04-24 | DAY BY DAY | Buy | Buy | Maintains |
| 2022-03-31 | LIBERUM | Hold | Hold | Maintains |
| 2022-02-21 | HSBC | Hold | Hold | Maintains |
| 2021-10-20 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2021-03-31 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2021-03-31 | LIBERUM | Hold | Hold | Maintains |
| 2023-12-14 | BERENBERG | Buy | Hold | Downgrade |
| 2023-11-27 | HSBC | Buy | Buy | Maintains |
| 2023-11-27 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-07 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-10-27 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-10-19 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-09-25 | DAY BY DAY | Sell | Sell | Maintains |
| 2023-09-04 | BERENBERG | Buy | Buy | Maintains |
| 2023-08-30 | BERENBERG | Buy | Buy | Maintains |
| 2023-08-28 | HSBC | Hold | Buy | Upgrade |
| 2023-08-17 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-07 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Hold | Downgrade |
| 2023-08-03 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-08-03 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-07-28 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2023-07-28 | DZ BANK | Hold | Hold | Maintains |
| 2023-07-27 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-06-02 | BERENBERG | Hold | Buy | Upgrade |
| 2023-06-01 | REDBURN LIMITED | Buy | Buy | Maintains |
| 2023-05-29 | DAY BY DAY | Buy | Sell | Downgrade |
| 2023-05-15 | SOCIETE GENERALE | Hold | Buy | Upgrade |
| 2023-05-10 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-05-08 | WOLFE RESEARCH | Outperform | Outperform | Maintains |
| 2023-04-27 | CREDIT SUISSE - EUROPE | Neutral | Outperform | Upgrade |
| 2023-04-27 | DZ BANK | Hold | Hold | Maintains |
| 2023-04-26 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2023-08-29 | BERENBERG | Buy | Buy | Maintains |
| 2023-08-27 | HSBC | Hold | Buy | Upgrade |
| 2023-08-16 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-08-06 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Hold | Downgrade |
| 2023-08-02 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-08-02 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-07-27 | CREDIT SUISSE - EUROPE | Outperform | Outperform | Maintains |
| 2023-07-27 | DZ BANK | Hold | Hold | Maintains |
| 2023-07-26 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2024-08-07 | BERENBERG | Hold | Hold | Maintains |
| 2024-08-05 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-08-01 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2024-07-31 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2024-07-25 | DZ BANK | Hold | Buy | Upgrade |
| 2024-07-25 | LANDESBANK BADEN-WUERTTEMBERG | Hold | Buy | Upgrade |
| 2024-07-24 | TD COWEN | Hold | Hold | Maintains |
| 2024-05-26 | HSBC | Buy | Buy | Maintains |
| 2024-03-03 | DAY BY DAY | Sell | Sell | Maintains |
| 2024-02-05 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-12-13 | BERENBERG | Buy | Hold | Downgrade |
| 2023-11-26 | HSBC | Buy | Buy | Maintains |
| 2023-11-26 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2023-11-06 | SOCIETE GENERALE | Buy | Buy | Maintains |
| 2023-10-26 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2023-10-18 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-09-24 | DAY BY DAY | Sell | Sell | Maintains |
| 2023-09-03 | BERENBERG | Buy | Buy | Maintains |
| 2025-01-06 | BERENBERG | Hold | Hold | Maintains |
| 2024-12-08 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2024-11-24 | HSBC | Buy | Buy | Maintains |
| 2024-11-19 | TD COWEN | Hold | Hold | Maintains |
| 2024-11-03 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2024-10-24 | DZ BANK | Buy | Buy | Maintains |
| 2024-10-23 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2024-10-23 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2024-10-13 | DAY BY DAY | Sell | Hold | Upgrade |
| 2025-04-07 | BERENBERG | Hold | Hold | Maintains |
| 2025-04-06 | TD COWEN | Hold | Hold | Maintains |
| 2025-03-23 | HSBC | Buy | Buy | Maintains |
| 2025-03-21 | REDBURN ATLANTIC | Buy | Buy | Maintains |
| 2025-03-11 | JEFFERIES | Hold | Hold | Maintains |
| 2025-03-02 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2025-02-02 | DZ BANK | Buy | Buy | Maintains |
| 2025-02-02 | LANDESBANK BADEN-WUERTTEMBERG | Buy | Buy | Maintains |
| 2025-01-21 | INTESA SANPAOLO EQUITY RESEARCH | Hold | Hold | Maintains |
| 2025-07-17 | BERENBERG | Hold | Hold | Maintains |
| 2025-07-13 | TD COWEN | Hold | Hold | Maintains |
| 2025-07-01 | ROTHSCHILD & CO REDBURN | Buy | Buy | Maintains |
| 2025-06-04 | JEFFERIES | Hold | Hold | Maintains |
| 2025-05-25 | HSBC | Buy | Hold | Downgrade |
| 2025-04-27 | DZ BANK | Buy | Buy | Maintains |
